1778 studies found for:    Open Studies | "Liver Diseases"
Show Display Options
Rank Status Study
21 Recruiting Hepatic Venous Pressure Gradient and Platelet Activation in Chronic Liver Disease
Condition: Chronic Liver Disease
Intervention:
22 Recruiting An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
Conditions: Psoriasis Chronic;   Liver Fibrosis;   Fatty Liver;   Non-alcoholic Fatty Liver Disease
Intervention: Device: Transient elastography
23 Recruiting Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
Condition: Parenteral Nutrition Associated Liver Disease
Intervention: Drug: Omegaven
24 Unknown  Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.
Conditions: Allogene MSCs Transplantation;   Chronic Liver Diseases Patients;   Peripheral Vein
Intervention:
25 Recruiting Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).
Condition: Polycystic Liver Disease
Intervention: Other: PLD-Q
26 Recruiting Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Conditions: Insulin Resistance;   Nonalcoholic Fatty Liver Disease
Intervention:
27 Recruiting Genetic Studies of Non-Alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Liver Cirrhosis;   Non-Alcoholic Fatty Liver Disease;   Liver Transplantation;   Genetics
Intervention:
28 Unknown  Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Procedure: Phlebotomy
29 Recruiting Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Behavioral: Experimental: Low-fructose, reduced carbohydrate diet;   Behavioral: General Healthy Diet
30 Unknown  Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Lovaza;   Drug: placebo control
31 Unknown  Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease in Diabetic Patients
Conditions: Nonalcoholic Fatty Liver Disease (NAFLD).;   Nonalcoholic Steatohepatitis.;   Diabetes.
Interventions: Procedure: Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).;   Other: Low carbohydrate diet
32 Unknown  Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Drug: atorvastatin;   Behavioral: lifestyle counseling
33 Recruiting The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
Condition: Non-alcoholic Fatty Liver Disease (NAFLD)
Intervention: Drug: Acetaminophen
34 Not yet recruiting The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Dietary Supplement: β- glucan;   Dietary Supplement: Maltodextrin
35 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platelet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
36 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platelet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
37 Recruiting Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases
Conditions: Malnutrition;   Liver Diseases, Alcoholic
Interventions: Device: Gastric tube (Nutricia Flocare® Pur Tube Enlock);   Device: Jejunal tube (Nutricia Flocare® Bengmark®)
38 Recruiting Baclofen in the Treatment of Alcoholic Liver Disease
Conditions: Alcoholic Liver Disease;   Alcohol Dependence
Interventions: Drug: Baclofen 30mg/day;   Drug: Baclofen 75mg/day;   Drug: Placebo
39 Unknown  Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Condition: End Stage Liver DIsease
Intervention: Drug: Mobilization with G-CSF and Mozobil
40 Recruiting Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM
Conditions: Liver Disease;   Heart Failure
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years